Skip to main content
HLB bioStep Co.,Ltd. logo

HLB bioStep Co.,Ltd. — Investor Relations & Filings

Ticker · 278650 ISIN · KR7278650007 KO Professional, scientific and technical activities
Open in API
Filings indexed 326 across all filing types
Latest filing 2022-03-15 AGM Information
Country KR South Korea
Listing KO 278650

About HLB bioStep Co.,Ltd.

http://hlbbiostep.com/en/

HLB bioStep Co.,Ltd. is a non-clinical Contract Research Organization (CRO) that provides a range of testing services to pharmaceutical companies and bio ventures. The company's core services support new drug development and include efficacy testing, pharmacokinetic/toxicokinetic (PK/TK) studies, and toxicology evaluations. A key area of specialization is veterinary medicine; HLB bioStep is an institution approved to conduct non-clinical tests and clinical trials for veterinary drugs. It also offers consulting services for regulatory approval procedures. The company utilizes various platform technologies, such as cell-enzyme-based screening and xenograft assays, and provides a comprehensive 'One-Stop Service' that leverages its experience in building laboratory facilities.

Recent filings

Filing Released Lang Actions
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Knotus Co., Ltd. It contains the agenda for the 10th Annual General Meeting, including the approval of financial statements, election of directors, and remuneration limits. It also includes detailed financial statements (balance sheet, income statement, statement of changes in equity) as part of the meeting materials provided to shareholders. This document serves as the official proxy solicitation and information package for the upcoming AGM, which falls under the 'Proxy Solicitation & Information Statement' category.
2022-03-15 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의). It outlines the date, location, and specific agenda items for the upcoming Annual General Meeting, including the approval of financial statements, election of directors, and amendments to the articles of incorporation. This type of document is a standard proxy solicitation or notice of meeting material provided to shareholders to inform them of the meeting and request their participation/votes.
2022-03-15 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing submitted by the company 'Notus' regarding the scheduling of its Annual General Meeting (AGM) on a 'concentrated date' (a date when many companies hold their AGMs). It explains the rationale for the chosen date and acknowledges the company's participation status in a voluntary compliance program. Since this is a specific regulatory disclosure regarding meeting logistics rather than the meeting materials themselves, the proxy statement, or the results, it falls under the general regulatory filing category.
2022-03-15 Korean
주식매수선택권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from a Korean company (Noteus) regarding the exercise of stock options (주식매수선택권행사). It details the number of shares exercised, the exercise price, the individuals involved, and the impact on total shares. This type of disclosure regarding the issuance of new shares resulting from stock option exercises falls under the category of share capital changes or share issuance announcements.
2022-03-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as the '5% rule' report). It details changes in share ownership by a major shareholder (HLB Co., Ltd.) and its special related parties in the company 'Notus'. This document is a mandatory disclosure filed with the Financial Supervisory Service (FSS) and the Korea Exchange (KRX) when shareholding thresholds are crossed or changed. It does not fit into categories like Annual Reports, Earnings Releases, or Investor Presentations, and is a formal regulatory disclosure of ownership status.
2022-03-03 Korean
[기재정정]최대주주변경을수반하는주식담보제공계약체결
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a 'Pledge of Shares' (stock collateral agreement) by a major shareholder. This type of disclosure, which involves changes to collateral agreements and potential changes in share ownership, is classified as a regulatory filing under the 'RNS' category as it does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for company capital changes).
2022-02-11 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.